WEBINAR

Accelerating Peptide Development: Strategies to optimize the formulation and manufacture of peptide therapeutics

Register here
  • Pediatric formulation and product development

    Quotient has extensive knowledge and capabilities that enable us to provide you with a unique integrated pediatric development solution. Our scientists have considerable experience in developing palatable formulations in the OTC/consumer health care industry and have successfully developed customized pediatric pharmaceutical formulations which have received regulatory approval.

    We have an extensive track record developing age-appropriate dosage forms of aversive, bitter drug substances using a range of taste-modifying and taste-masking techniques without compromising on product stability and PK performance.

  • Oncology drug development

    Quotient supports oncology drug development from candidate selection through to commercial manufacture and supply.

    In the past 5 years alone, we have successfully worked on over 300 oncology development projects for 91 different oncology drug candidates, spanning 34 different disease indications. Our extensive formulation expertise coupled with our agile and flexible approach to clinical and commercial manufacturing makes us the ideal partner to provide an end-to-end solution for the development of oncology drug products.

  • Orphan drug development for rare diseases

    Orphan drug development for rare diseases

    Quotient has supported over 50 development programs for rare disease in the past 5 years. Our extensive formulation know-how, clinical pharmacology expertise, coupled with our agile and flexible approach to clinical and commercial manufacturing, makes us the ideal partner.

    From pre-formulation and formulation development through clinical development and scale up for commercial manufacturing we provide an end-to-end solution for the development of orphan drug products.

  • Inhaled drug development

    Quotient has a 30 year track record in the development and manufacturing of inhaled drug products. We have experience across a range of drug delivery platforms including dry powder inhalers (DPIs) and solutions/suspensions for inhalation.

    With integrated capabilities and vast knowledge of nasal and pulmonary delivery, we help our clients accelerate their molecules from first-in-human, through to proof-of-concept and into full development.

Orphan drug development for rare diseases
We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.